Mountable Printable Placard With Headband
A resilient headband in a shape for being mounted on the head of the user. The headband is equipped with a longitudinal slotted member for holding a placard.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8183270 | Insecticidal -substituted (2-substituted-1,3-thiazol)alkyl sulfoximines N-Substituted (2-substituted-1,3-thiazol)alkyl sulfoximines are effective at controlling insects. ... | 05/22/2012 |
| 8178566 | Crystal form of epothilone B and use in pharmaceutical compositions The invention relates to new crystal forms of epothilone B. ... | 05/15/2012 |
| 8148411 | 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals The present invention relates to 2-hetarylthiazole-4-carboxamide derivatives of the formula (I), the use thereof as medicament for the treatment of various disorders, and processes for the preparation thereof ... | 04/03/2012 |
| 8114897 | Pesticidal composition and method for controlling a pest A pesticidal composition containing 4-methoxymethyl-2,3,5,6-tetrafluorobenzyl 3-(2-cyano-1-propenyl)-2,2-dimethylcyclopropanecarboxylate and 1-(2-chloro-1,3-thiazolyl)methyl-3-methyl-2-nitroguanidine has a high pesticidal activity. ... | 02/14/2012 |
| 8110590 | Synthesis of epothilones, intermediates thereto and analogues thereof The present invention provides compounds of formula (I): as described generally and in classes and subclasses herein. The present invention additionally provides pharmaceutical compositions comprisi... | 02/07/2012 |
| 8106078 | Human protein tyrosine phosphatase inhibitors and methods of use The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPT... | 01/31/2012 |
| 8088804 | N-hydroxyamide derivatives possessing antibacterial activity Described herein are N-hydroxyamide antibacterial compounds, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical compositions compound of Formu... | 01/03/2012 |
| 8071633 | Pharmaceutical composition for treating This invention provide to a pharmaceutical composition for treating spinocerebellar ataxia (or atrophy, degeneration) or multiple system atrophy, or for improving ataxia or equilibrium disturbance comprising a compound of the formula (I): | 12/06/2011 |
| 8067449 | Modulators of pharmacokinetic properties of therapeutics The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods... | 11/29/2011 |
| 8048900 | Use of 15-lipoxygenase inhibitors for treating obesity The invention concerns the treatment of obesity, in particular abdominal visceral obesity. More specifically, the invention concerns the use of selective 15-lipoxygenase (LO) inhibitors for preparing medicines useful in the treatment of obesity, or at least abdomina... | 11/01/2011 |
| 8039495 | Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 10/18/2011 |
| 8026263 | Methods for inhibiting neoproliferative changes in blood vessel walls Methods, compositions and devices for inhibiting neoproliferative changes in blood vessel walls or other anatomical structures. One or more compounds of Formula I or I-A set forth herein are administered systemically and/or locally to human or veterinary patients to... | 09/27/2011 |
| 8008330 | Combinations comprising epothilones and pharmaceutical uses thereof The invention relates to a combination which comprises (a) a bisphosphonate, a platinum compound or a vasculostatic compound and (b) an epothilone derivative of formula I wherein A represents O or NRN, wherein R | 08/30/2011 |
| 8008329 | Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmacuetical composition comprising benzamidine derivative or it's salt, and bisphosphonate The present invention provides a method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivative or its salt, and bisphosphonate for the purpose o... | 08/30/2011 |
| 7994202 | Bicyclic nitrogen-containing heterocyclic compounds A nitrogen-containing bicyclic heterocyclic compound represented by the following formula (1) is provided. When the compound or a salt thereof is administered to a human being or an animal, the compound has a strong antagonistic action against EP1 receptors, and is ... | 08/09/2011 |
| 7989480 | Aryl amino acid derivatives as inhibitors for treating inflammation The present invention relates to a chemical genus of 3-(triaryl)-2-aminopropanol derivative inhibitors of LTA4H (leukotriene A4 hydrolase) useful for the treatment and prevention of inflammatory diseases and disorders. The compounds have general formula III: ... | 08/02/2011 |
| 7981911 | Pharmaceutical formulations Improved pharmaceutical compositions are provided comprising one or more solubilized HIV protease inhibiting compounds having improved solubility properties in a medium and/or long chain fatty acid, or mixtures thereof, a pharmaceutically acceptable alcohol, and wat... | 07/19/2011 |
| 7977363 | Biphenyl-thiazolo-carboxamides Novel biphenyl thiazole carboxamides of Formula (I) where R1, R2, R3, R4, R5 and n have the meanings specified in the description, several method... | 07/12/2011 |
| 7968575 | Nitric oxide donors and uses thereof Disclosed are novel NO-donating compounds, designed such that when NO is released from the compound a residue which is a naturally occurring metabolite is formed, and thus a development of tolerance to the compounds upon repetitive administration is prevented or dec... | 06/28/2011 |
| 7964622 | Indole acetic acid derivatives and their use as pharmaceutical agents This invention is directed to indole acetic acid derivatives and their use in pharmaceutical compositions for the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease. The invention is also directed to intermediates useful in ... | 06/21/2011 |
| 7956075 | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments The invention relates to thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives of general formula (I) wherein Het is thiazole, oxazole, imidazole, isoxazole or isoxazoline, n is an integer from 0 to 6, A is no... | 06/07/2011 |
| 7943646 | Benzamidine derivative, process for the preparation thereof and pharmaceutical composition comprising same The present invention relates to a novel benzamidine derivative, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The benzamidine derivative of the present invention effectively inhibits osteoclast differentiation at an ex... | 05/17/2011 |
| 7939553 | Modulators of pharmacokinetic properties of therapeutics The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration... | 05/10/2011 |
| 7902236 | Antagonists of the vanilloid receptor subtype 1 (VR1) and use thereof The present invention is directed to compounds of formula (I) wherein variables W, X, Y, D, A, n, R1, R2 and R9 are as defined in the description. ... | 03/08/2011 |
| 7897626 | 2-substituted thiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals The present invention relates to 2-substituted thiazole-4-carboxamide derivatives of the formula (I), the use thereof as medicament for the treatment of various disorders, and processes for the preparation thereof ... | 03/01/2011 |
| 7893097 | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water The combination of any two of a polyol, a polyol ether, and a low carbon organic alcohol provides a synergistic effect on the solubility of azole compounds, such as metronidazole, in aqueous fluid. ... | 02/22/2011 |
| 7879886 | Iron binding agents Composition, article of manufacture for and method of treating malaria in a human having an infestation of Plasmodium protozoans are described. The method comprises administering a therapeutically-effective amount of a compound of formula (I) or (IV), i.e. su... | 02/01/2011 |
| 7875638 | Synthesis of epothilones, intermediates thereto, analogues and uses thereof The present invention provides compounds of formula (I): as described generally and in classes and subclasses herein. The present invention additionally provides pharmaceutical compositions comprisi... | 01/25/2011 |
| 7863303 | Insecticidal -substituted (2-substituted-1,3-thiazol)alkyl sulfoximines N-Substituted (2-substituted-1,3-thiazol)alkyl sulfoximines are effective at controlling insects. ... | 01/04/2011 |
| 7863304 | Analogs of glycyl-prolyl-glutamate Embodiments of this invention include novel analogs of Glycyl-Prolyl-Glutamate (GPE) and compositions containing such analogs of GPE. Of these, certain analogs have modified proline residues. Other embodiments of this invention include uses of analogs of GPE to prot... | 01/04/2011 |
| RE41990 | Synthesis of epothilones, intermediates thereto, analogues and uses thereof The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof. Also provided are analogues related to epothilone A and B and intermediates useful for preparing same. The present invention furth... | 12/07/2010 |
| 7846952 | Epothilones C, D, E, and F, preparation and compositions The present invention relates to epothilones C, D, E, and F, their preparation and their use for the production of therapeutic compositions and compositions for plant protection. ... | 12/07/2010 |
| 7846951 | Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to meth... | 12/07/2010 |
| 7825141 | Epothilone derivatives Epothilone derivatives of Formula (I) and their use as a pharmaceutical. ... | 11/02/2010 |
| 7825142 | Heterocyclic compounds, compositions comprising them and methods of their use Heterocyclic compounds, compositions comprising them, and methods of their use for the treatment, prevention and management of inflammatory and autoimmune diseases and disorders are disclosed. Particular compounds are of formula I: | 11/02/2010 |
| RE41911 | Epothilone derivatives The present invention relates to epothilone derivatives, having the following formula in which the variables G, W, Q, X, Y, B1, B2, Z1, Z2, and R1-R7 are as define... | 11/02/2010 |
| RE41895 | Epothilone derivatives The present invention relates to epothilone derivatives, having the following formula in which the variables G, W, Q, X, Y, B1, B2, Z1, Z2, and R1-R7 are as define... | 10/26/2010 |
| 7812041 | Heterocyclic NF-κB inhibitors The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, wherein R1 is independently hydrogen; alkyl, cycloalkyl, hydroxyalk... | 10/12/2010 |
| 7803823 | 2-amino-4,5-trisubstituted thiazolyl derivatives This invention concerns the use of a compound of formula (I′) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein Z is halo; C1-6alky... | 09/28/2010 |
| 7799813 | Salts of substituted 5-membered azacycle and use thereof in the treatment of diseases related to protein aging The present invention relates to 5-membered azacycle compounds of formula (I), pharmaceutically acceptable salts thereof and hydrates thereof, wherein the groups are as defined in the specification. The present invention further relates to pharmaceutical composition... | 09/21/2010 |